Active TB Drug Safety Monitoring [aDSM]
H5ContentPharmacovigilance in NTEP
H5ContentADRs to Second Line Treatment
H5ContentManagement of ADR: Rash, Allergy and Anaphylaxis Reaction
H5ContentManagement of DR-TB ADR: Gastritis, abdominal pain
H5ContentManagement of DR-TB ADR: Diarrhoea and/or Flatulence
H5ContentManagement of DR-TB ADR: Hepatitis
H5ContentManagement of DR-TB ADR: Giddiness
H5ContentManagement of DR-TB ADR: QT Prolongation
H5ContentManagement of DR-TB ADR: Hematological Abnormalities
H5ContentManagement of DR-TB ADR: Hypothyroidism
H5ContentManagement of DR-TB ADR: Arthralgia
H5ContentManagement of DR-TB ADR: Peripheral Neuropathy
H5ContentManagement of DR-TB ADR: Psychotic Symptoms
H5ContentManagement of DR-TB ADR: Nephrotoxicity [Renal Toxicity]
H5ContentManagement of DR-TB ADR: Vestibular Toxicity
H5Content
for the National TB Elimination Program - NTEP